Cloud-Based Rare Disease Family Registry Market Report 2026

Cloud-Based Rare Disease Family Registry Market Overview

• Cloud-Based Rare Disease Family Registry market size has reached to $1.4 billion in 2025 • Expected to grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 17.5% • Growth Driver: Increasing Focus On Precision Medicine Is Fueling The Growth Of The Market Due To Advances In Genomic Sequencing And Rising Approvals Of Personalized Therapies • Market Trend: Innovations In Cloud-Based Patient Registries For Enhanced Rare Disease Research And Collaboration • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Cloud-Based Rare Disease Family Registry Market?

A cloud-based rare disease family registry refers to an online platform that securely collects, stores, and manages health and family information related to rare diseases. It allows patients, families, and healthcare professionals to share data from anywhere, helping improve research, care, and clinical trial recruitment. The main components of a cloud-based rare disease family registry are software and services. Software is a collection of programs, data, and instructions that tell a computer or device how to perform specific tasks or operations. The multiple deployment modes are public cloud, private cloud, and hybrid cloud. The various applications involved are patient data management, research, clinical trials, genetic data collection, and others, and they are used by several end users such as hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, patient advocacy groups, and others.

What Is The Cloud-Based Rare Disease Family Registry Market Growth Forecast?

The cloud-based rare disease family registry market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing investments in orphan drug development, rising demand for real-world evidence generation, expansion of precision medicine research, growing use of ai-driven data analytics, increasing emphasis on patient-centric research models. Major trends in the forecast period include increasing adoption of cloud-based patient registries, rising use of digital platforms for rare disease research, growing integration of genomic and clinical data, expansion of global clinical trial recruitment tools, enhanced focus on secure data sharing.

Global Cloud-Based Rare Disease Family Registry Market Segmentation

1) By Component: Software, Services 2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud 3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications 4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users Subsegments: 1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System 2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades

What Is The Driver Of The Cloud-Based Rare Disease Family Registry Market?

The increasing focus on precision medicine is expected to propel the growth of the cloud-based rare disease family registry market going forward. Precision medicine is a medical approach that tailors treatment and prevention strategies to an individual’s genetic, environmental, and lifestyle factors. Precision medicine is increasing due to advances in genomic sequencing that allow doctors to understand patients’ genetic makeup more accurately. Cloud-based rare disease family registries support precision medicine by collecting and centralizing detailed patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases, marking a notable rise from the six approvals in 2022, of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Therefore, increasing focus on precision medicine is driving the growth of the cloud-based rare disease family registry industry.

Key Players In The Global Cloud-Based Rare Disease Family Registry Market

Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central

Global Cloud-Based Rare Disease Family Registry Market Trends and Insights

Major companies in the cloud-based rare disease family registry market are advancing technological innovations, such as bilingual federated registries, to provide patients, families, and researchers with secure, multi-location data platforms that enhance participation and support real-time data collection and analysis. A bilingual federated registry is a cloud-based system that allows data to remain at local sites while supporting multiple languages and complying with regional consent and privacy regulations. For instance, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, planned the launch of two Canadian patient registries for PKU and MPS. Developed in collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries are the first in the IAMRARE Program to be hosted outside the U.S. They are designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support efforts to accelerate research, improve understanding of rare metabolic disorders, and facilitate identification of participants for clinical trials.

What Are Latest Mergers And Acquisitions In The Cloud-Based Rare Disease Family Registry Market?

In May 2025, Vora Ventures, a US-based equity firm, acquired Hive Networks Inc. for an undisclosed amount. Through this acquisition, Vora Ventures aims to expand Hive Networks’ reach and impact by leveraging its cloud-based AI-powered platform to improve collaboration, data sharing, and patient outcomes in rare and chronic disease communities. Hive Networks Inc. is a US-based healthcare technology company that provides a cloud-based platform to be the collaborative infrastructure where patients, families, clinicians, and researchers can securely share data, insights, and best practices.

Regional Outlook

North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cloud-Based Rare Disease Family Registry Market?

The cloud-based rare disease family registry market consists of revenues earned by entities by providing services such as data hosting, data integration, data security, data sharing, data analytics, data storage, interoperability support, registry customization, patient engagement support, technical support, and training services, maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloud-based rare disease family registry market also includes sales of data storage devices, networking equipment, diagnostic kits, biometric devices, patient monitoring devices, data backup systems, security hardware, computing workstations, and mobile devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cloud-Based Rare Disease Family Registry Market Report 2026?

The cloud-based rare disease family registry market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cloud-based rare disease family registry industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.